Cerapedics Inc.

Stories

Medicare adds PearlMatrix bone graft to new-technology payment program

Developer and marketer of PearlMatrix and i-FACTOR bone grafts

Hospitals that use PearlMatrix, a peptide-enhanced bone graft proven to speed lumbar fusion, can now claim up to 65% of its added cost back from Medicare. The Centers for Medicare & Medicaid Services (CMS) granted the graft New Technology Add-on Payment (NTAP) status, effective October 1, 2026.

Updated Oct 2

The long road to FDA approval for spinal biologics

New Capabilities

Competitor with FDA-approved PearlMatrix P-15 bone graft

Medtronic's INFUSE bone graft has spent 24 years navigating FDA approval, off-label controversy, and lawsuits. The FDA just approved INFUSE for transforaminal lumbar interbody fusion (TLIF) procedures—the only growth factor bone graft approved for two-level spinal constructs and the only one cleared for anterior, oblique, and transforaminal approaches.

Updated May 29